Pancuroniumbromid Inresa (Pancuronium Bromide)

Pancuronium bromide, the active ingredient in Pancuroniumbromid Inresa, is a neuromuscular blocking agent presented as a sterile injectable solution for intravenous use. It provides skeletal muscle relaxation to facilitate endotracheal intubation and to maintain muscle relaxation during surgery.

GNH USA supplies Pancuroniumbromid Inresa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pancuronium bromide is used as a neuromuscular blocking agent to produce skeletal muscle relaxation during specific medical procedures.

- Facilitation of endotracheal intubation: provides rapid muscle relaxation to allow safe airway placement. - Muscle relaxation during surgery: maintains a relaxed surgical field for optimal operative conditions. - Adjunct in controlled ventilation: enables precise control of ventilation parameters during anesthesia.

Adverse reactions may occur with the use of pancuronium bromide.

Common Side Effects: - Hypotension: reduced blood pressure during administration. - Bradycardia: slower than normal heart rate. - Facial flushing: transient redness of the face. - Dry mouth: decreased salivation. - Nausea: feeling of sickness. - Vomiting: expulsion of gastric contents.

Serious or Rare Side Effects: - Prolonged apnea: extended respiratory paralysis requiring ventilation. - Anaphylactic reaction: severe allergic response with potential airway compromise. - Hyperkalemia: elevated serum potassium levels. - Malignant hyperthermia trigger: rare but life‑threatening hypermetabolic state. - Cardiac arrhythmias: irregular heart rhythms.

When using pancuronium bromide, careful monitoring and specific precautions are essential.

- Assess neuromuscular function: monitor depth of blockade with a peripheral nerve stimulator. - Avoid in patients with known hypersensitivity to pancuronium or related compounds. - Use with caution in cardiovascular disease: may cause tachycardia or hypertension. - Ensure adequate ventilation support: drug induces paralysis requiring mechanical ventilation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Pancuronium bromide can interact with several other agents; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Concurrent use with other non‑depolarizing neuromuscular blockers: additive paralysis. - Combination with aminoglycoside antibiotics: potentiates neuromuscular blockade. - Use with magnesium sulfate: enhances blockade.

Moderate Interactions (Monitor Closely): - Co‑administration with volatile anesthetics: may increase duration of action. - Interaction with cholinesterase inhibitors: may reduce effectiveness of pancuronium. - Concurrent use of calcium channel blockers: may modestly prolong neuromuscular effects.